1.61
price down icon4.17%   -0.07
after-market Dopo l'orario di chiusura: 1.60 -0.01 -0.62%
loading
Precedente Chiudi:
$1.68
Aprire:
$1.69
Volume 24 ore:
532.86K
Relative Volume:
1.25
Capitalizzazione di mercato:
$97.52M
Reddito:
-
Utile/perdita netta:
$-64.86M
Rapporto P/E:
-1.4375
EPS:
-1.12
Flusso di cassa netto:
$-55.66M
1 W Prestazione:
+8.78%
1M Prestazione:
+27.78%
6M Prestazione:
-2.42%
1 anno Prestazione:
-50.00%
Intervallo 1D:
Value
$1.54
$1.69
Intervallo di 1 settimana:
Value
$1.48
$1.73
Portata 52W:
Value
$0.8551
$3.60

Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile

Name
Nome
Acumen Pharmaceuticals Inc
Name
Telefono
925-368-8508
Name
Indirizzo
427 PARK ST., CHARLOTTESVILLE
Name
Dipendente
52
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
ABOS's Discussions on Twitter

Confronta ABOS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ABOS
Acumen Pharmaceuticals Inc
1.61 101.16M 0 -64.86M -55.66M -1.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-17 Iniziato Citigroup Buy
2024-07-26 Iniziato Citigroup Buy
2023-12-12 Iniziato Deutsche Bank Buy
2023-07-20 Ripresa BofA Securities Buy
2023-05-18 Iniziato Cantor Fitzgerald Overweight
2022-07-15 Iniziato BTIG Research Buy
2022-06-30 Iniziato H.C. Wainwright Buy
2022-01-21 Aggiornamento BofA Securities Neutral → Buy
2021-07-26 Iniziato BofA Securities Neutral
2021-07-26 Iniziato Credit Suisse Outperform
2021-07-26 Iniziato Stifel Buy
2021-07-26 Iniziato UBS Buy
Mostra tutto

Acumen Pharmaceuticals Inc Borsa (ABOS) Ultime notizie

pulisher
Jul 24, 2025

Does Acumen Pharmaceuticals Inc. stock pay reliable dividendsSuperior capital gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

How high can Acumen Pharmaceuticals Inc. stock price go in 2025Exceptional growth trajectory - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Is Acumen Pharmaceuticals Inc. stock overhyped or has real potentialPowerful market insights - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Acumen Pharmaceuticals shares rise 2.92% after-hours following European Commission approval of DARZALEX Faspro® for multiple myeloma. - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Is RNST a good long term investmentRapid-fire capital growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

European Commission Approved DARZALEX Faspro® for Adult Patients with Smouldering Multiple Myeloma - The Malaysian Reserve

Jul 23, 2025
pulisher
Jul 23, 2025

Is Neo Concept International Group Holdings Limited a good long term investmentHigh-performance investment picks - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Comcast Corporation stock priceOutstanding risk-reward balance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Acumen Pharmaceuticals Inc. stock priceSuperior capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Nila Spaces Limited (542231) Signs Major DealExplosive market performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is ARTW a good long term investmentFree Investment Community - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Nukkleus Inc. stockSuperior returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Acumen Pharmaceuticals Inc. stock price move sharplyFree Market Sentiment Analysis - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Acumen Pharmaceuticals Inc. Stock Analysis and ForecastDynamic investment growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What analysts say about Acumen Pharmaceuticals Inc. stockHigh-yield trading alerts - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Is Acumen Pharmaceuticals Inc. a good long term investmentFree Investment Timing Strategies - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

West Pharmaceutical's Strategic Shift: How Robert McMahon's Financial Acumen Positions the Company for GLP-1 Dominance - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Central Nervous System (CNS) Biomarkers Market is expected - openPR.com

Jul 21, 2025
pulisher
Jul 20, 2025

Is BKTI a good long term investmentRecord-breaking capital gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Published on: 2025-07-20 14:18:28 - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Rush Enterprises Inc. stockRapid wealth multiplication - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What analysts say about BOLD stockMarket-crushing profits - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Blue Chip Stocks Investor Friendly Stock ChoicesFree Capital Allocation Plans - Jammu Links News

Jul 18, 2025
pulisher
Jul 16, 2025

Acumen and JCR enter collaboration to develop BBB-penetrating Alzheimer’s treatment - BioWorld MedTech

Jul 16, 2025
pulisher
Jul 16, 2025

JCR Pharma links up with Acumen on Alzheimer’s research - The Pharma Letter

Jul 16, 2025
pulisher
Jul 16, 2025

Acumen and JCR partner on brain delivery therapy for Alzheimer’s - Yahoo Finance

Jul 16, 2025
pulisher
Jul 16, 2025

ai for factory safety and hazard detectionSafety First Trading Signals - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Acumen Pharmaceuticals Inc. stock attracts strong analyst attentionSafer Investing With Bigger Upside - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How CURRENC Group Inc. stock performs during market volatilitySafe and Scalable Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Acumen Pharmaceuticals Inc (ABOS) Stock: A Comprehensive 52-Week Review - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

How Acumen Pharmaceuticals Inc. stock performs during market volatilityFree Exclusive Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why LINKBANCORP Inc. stock attracts strong analyst attentionPotential Rocket List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Veeco Instruments Inc. stock attracts strong analyst attentionFree Top Growth Stock Recommendations - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How SELX stock performs during market volatilityVerified Return Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Acumen, JCR partner on brain barrier technology for Alzheimer’s treatment By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Compass Therapeutics And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Acumen Pharmaceuticals, JCR to Develop Alzheimer's Disease Therapy - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Acumen, JCR partner on brain barrier technology for Alzheimer’s treatment - Investing.com Australia

Jul 15, 2025
pulisher
Jul 15, 2025

ABOS SEC FilingsAcumen Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 15, 2025

Acumen Pharmaceuticals Inc Azioni (ABOS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):